Patients sue GLP-1 drugmakers, alleging severe side effects
(NewsNation) — As weight loss drugs become increasingly popular, thousands of patients have filed lawsuits against the companies behind GLP-1 medications, alleging severe health effects.
Since 2023, roughly 4,400 patients have filed lawsuits against weight loss drugmakers — including Novo Nordisk, which makes Ozempic and Wegovy, and Eli Lilly, which produces Mounjaro, Zepbound and Trulicity — according to USA Today.
The plaintiffs, who range in age from 18 to 87, have pointed to severe, undisclosed side effects, including blindness, loss of brain function and organ damage. About 75% of plaintiffs say they have been left with gastroparesis, a condition that delays stomach emptying, while another 8% report extreme gastrointestinal injuries.
https://www.newsnationnow.com/health/glp-1-drugmakers-side-effects-lawsuit/